ALREX - 24208-353-10 - (loteprednol etabonate)

Alphabetical Index


Drug Information of ALREX

Product NDC: 24208-353
Proprietary Name: ALREX
Non Proprietary Name: loteprednol etabonate
Active Ingredient(s): 2    mg/mL & nbsp;   loteprednol etabonate
Administration Route(s): OPHTHALMIC
Dosage Form(s): SUSPENSION/ DROPS
Coding System: National Drug Codes(NDC)

Labeler Information of ALREX

Product NDC: 24208-353
Labeler Name: Bausch & Lomb Incorporated
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020803
Marketing Category: NDA
Start Marketing Date: 19980309

Package Information of ALREX

Package NDC: 24208-353-10
Package Description: 1 BOTTLE, DROPPER in 1 CARTON (24208-353-10) > 10 mL in 1 BOTTLE, DROPPER

NDC Information of ALREX

NDC Code 24208-353-10
Proprietary Name ALREX
Package Description 1 BOTTLE, DROPPER in 1 CARTON (24208-353-10) > 10 mL in 1 BOTTLE, DROPPER
Product NDC 24208-353
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name loteprednol etabonate
Dosage Form Name SUSPENSION/ DROPS
Route Name OPHTHALMIC
Start Marketing Date 19980309
Marketing Category Name NDA
Labeler Name Bausch & Lomb Incorporated
Substance Name LOTEPREDNOL ETABONATE
Strength Number 2
Strength Unit mg/mL
Pharmaceutical Classes Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]

Complete Information of ALREX


General Information